The Need for Longer-Lasting PAD Solutions With DCB Technology | Chapter II

This program outlines the essential need for longer-lasting peripheral arterial disease (PAD) solutions for complex lesions using drug-coated balloon therapy. Join us for this live, 60-minute panel discussion with leading physician experts describing the latest safety data and their continued practice with the Lutonix™ Drug-Coated Balloon Platform. Highlights include:

• The Latest Safety on Paclitaxel: SWEDEPAD, presented by the National Principal Investigator
• Drug-Eluting Therapy: The Critical Role It Plays in Everyday PAD Practice
• Real-World Case Applications With Lutonix™ DCB

Andrej Schmidt, MD
​​​​​​Interventional Cardiologist and Angiolist, Department of Angiology, University Hospital, Leipzig, Germany;

Sabrina Houthoofd, MD
​​​​​Vascular Surgeon, Universitair Ziekenhuis, Leuven, Belgium

Marten Falkenberg, MD
​​​​​​Vascular Surgeon, Department of Radiology, Sahlgrenska University Hospital, Gothenburg, Sweden

Joakim Nordanstig, MD
​​​​​Senior Vascular Surgeon, Vascular Researcher, Sahlgrenska University Hospital, Gothenburg, Sweden

Yvonne Bausback, MD
​​​​​Interventional Cardiologist and Angiologist, Department of Angiology, University Hospital, Leipzig, Germany